Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069213
Filing Date
2025-05-12
Accepted
2025-05-12 16:12:00
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ocx-20250331.htm   iXBRL 10-Q 2566684
2 EX-31.1 ocx-ex31_1.htm EX-31.1 14581
3 EX-31.2 ocx-ex31_2.htm EX-31.2 14514
4 EX-32.1 ocx-ex32_1.htm EX-32.1 10725
  Complete submission text file 0000950170-25-069213.txt   12212431

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ocx-20250331.xsd EX-101.SCH 1663039
71 EXTRACTED XBRL INSTANCE DOCUMENT ocx-20250331_htm.xml XML 2470859
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 25934944
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)